08:00 , Mar 3, 2014 |  BC Week In Review  |  Company News

Immunome management update

Immunome Inc. , Wynnewood, Pa.   Business: Infectious, Antibodies   Hired: Joan Lau as COO, formerly president and CEO of Azelon Pharmaceuticals Inc. ; and Joel Sussman as CFO  ...
07:00 , Oct 17, 2011 |  BC Week In Review  |  Company News

Azelon management update

Azelon Pharmaceuticals Inc. , West Conshohocken, Pa.   Business: Musculoskeletal   Hired: Joan Lau as president and CEO, formerly CEO of Locus Pharmaceuticals Inc. , she succeeds Brian MacDonald, who will remain as a senior...
07:00 , Oct 17, 2011 |  BC Week In Review  |  Financial News

Azelon completes venture financing

Azelon Pharmaceuticals Inc. , West Conshohocken, Pa.   Business: Musculoskeletal   Date completed: 10/10/11   Type: Venture financing   Raised: $4.5 million   Investors: Prospect Venture Partners; Lighthouse Capital Partners; Covington Venture Fund  ...
07:00 , Oct 17, 2011 |  BC Week In Review  |  Company News

Azelon Pharmaceuticals Inc board of directors update

Azelon Pharmaceuticals Inc ., West Conshohocken, Pa.   Business: Musculoskeletal   Appointed: Don Hayden as executive chairman, formerly EVP and president of Americas at Bristol-Myers Squibb Co.  ...
07:00 , Oct 10, 2011 |  BioCentury  |  Finance

Venture's stress

Prospect Venture Partners created surprise and unease last week when it decided $150 million was not enough to support a new fund and released its LPs from their commitments. It now remains to be seen...
07:00 , Oct 3, 2011 |  BC Week In Review  |  Company News

Elevation Pharmaceuticals management update

Elevation Pharmaceuticals Inc. , San Diego, Calif.   Business: Pulmonary   Hired: Jaisim Shah as SVP and CBO, formerly president of Zelos Therapeutics Inc. ; and Pravin Soni as SVP and chief technical officer, both...
08:00 , Feb 22, 2010 |  BC Week In Review  |  Company News

Tarsa Therapeutics management update

Tarsa Therapeutics Inc. , Philadelphia, Pa.   Business: Musculoskeletal   Hired: David Krause as CMO, formerly CMO, SVP and head of R&D at Zelos Therapeutics Inc.  ...
08:00 , Feb 18, 2010 |  BC Innovations  |  Cover Story

Gut punch to osteoporosis

U.S. and Indian researchers have shown that blocking the production of serotonin in the gut with a tryptophan hydroxylase 1 inhibitor from Lexicon Pharmaceuticals Inc. can increase bone formation to treat or prevent osteoporosis. 1...
08:00 , Feb 1, 2010 |  BC Week In Review  |  Clinical News

Teriparatide: Phase I started

Zelos began a Phase I trial to compare an intranasal formulation of ZT-034 vs. injectable Forteo teriparatide for 7 days in 50 healthy postmenopausal women. Zelos developed the intranasal formulation using Intravail permeation enhancer technology...
08:00 , Jan 21, 2010 |  BC Innovations  |  Targets & Mechanisms

Oncostatin's LIFR sentence

A key challenge in developing osteoporosis therapies that actually promote bone growth-most marketed drugs stop bone loss-is uncoupling the tightly related processes of bone formation and resorption. Now, a group of Australian researchers has found...